Core Insights - The Zacks Rank system emphasizes earnings estimates and revisions to identify winning stocks, with a focus on value investing as a preferred strategy in various market conditions [1][2] Company Analysis - GARRETT MOTION (GTX) is currently rated as a Zacks Rank 1 (Strong Buy) with a Value grade of A, trading at a P/E ratio of 9.45 compared to the industry average of 22.02 [3] - Over the past year, GTX's Forward P/E has fluctuated between a high of 9.56 and a low of 5.83, with a median of 7.57 [3] - The P/S ratio for GTX is 0.78, slightly below the industry average of 0.8, indicating potential undervaluation [4] - LCI Industries (LCII) holds a Zacks Rank of 2 (Buy) and a Value grade of A, with a P/B ratio of 1.78 compared to the industry's 3.71 [5] - The P/B ratio for LCII has ranged from a high of 2.27 to a low of 1.39, with a median of 1.86 over the past year [5] - Both GTX and LCII are considered likely undervalued stocks, supported by their strong earnings outlooks [6]

Group 1 - Healthpeak Properties (NYSE: DOC) is a leading REIT with over 700 properties focused on outpatient and lab properties [1] - The stock of Healthpeak Properties has been weak in the recent environment [1] Group 2 - The analyst has over 10 years of experience researching companies across various sectors, including commodities and technology [1] - The analyst has researched over 1000 companies and has a preference for covering metals and mining stocks, but is also comfortable with other industries such as consumer discretionary/staples, REITs, and utilities [1]

Core Insights - The analysis focuses on value investing with a long-term perspective, emphasizing an owner's mindset rather than short-term trading strategies [1] Group 1 - The analyst does not engage in short selling and does not write sell articles, indicating a preference for long positions [1] - There is a potential intention to initiate a long position in ZIM within the next 72 hours, suggesting a positive outlook on the stock [2] - The article reflects the analyst's personal opinions and is not influenced by any compensation from companies mentioned [2] Group 2 - The article does not provide specific investment recommendations or advice tailored to individual investors, highlighting a general approach to investment analysis [3] - It is noted that past performance does not guarantee future results, which is a standard disclaimer in investment analysis [3] - The authors of the analysis may include both professional and individual investors, indicating a diverse range of perspectives [3]

Advanced Micro Devices, Inc. ( AMD ) is a stock I've covered a few times. Each time, I've been hesitant, if only because the multiple seemed too high to give a good, long-term return. A big announcement about a dealI analyze securities based on value investing, an owner's mindset, and a long-term horizon. I don't write sell articles as those are considered short theses, and I never recommend shorting.Former advisory representative at Fidelity. I do my own investing now and share my research here.Analyst’s D ...

Investors interested in stocks from the Gaming sector have probably already heard of Boyd Gaming (BYD) and Take-Two Interactive (TTWO) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies w ...

Core Viewpoint - Viking Therapeutics, Inc. (NASDAQ: VKTX) is positioned as a leading player in the GLP-1 weight-loss drug market, presenting a relatively de-risked investment opportunity [1]. Company Analysis - The company focuses on identifying reasonably priced firms with steady long-term growth prospects and small- to mid-cap companies that have the potential for exponential growth [1]. - Viking Therapeutics is involved in the development of innovative therapies, particularly in the weight-loss sector, which is gaining significant attention in the pharmaceutical industry [1]. Investment Perspective - The analysis emphasizes the importance of fundamental analysis of businesses, financials, and valuations to uncover potential investment opportunities [1]. - The author believes that educated individuals can outperform the market by understanding basic accounting and financial principles, which may apply to investors considering Viking Therapeutics [1].

Investment Strategy - The investor adopts a global approach to identify undervalued companies that provide a significant margin of safety, leading to attractive dividend yields and returns [1] - Focus is placed on companies that the investor thoroughly understands and can reasonably assess for future growth potential [1] Valuation Metrics - The investor shows particular enthusiasm for companies with a solid earnings track record that are trading at less than 8 times free cash flow [1]

Core Insights - The ETF market is experiencing significant net inflows, exceeding $923 billion this year, indicating strong investor appetite and positioning for another trillion-dollar year [1][2]. ETF Market Trends - The top inflows this week were seen in the Vanguard Information Technology Index Fund (VGT), a gold ETF (GLD), and the Financial Select Sector SPDR Fund (XLF), reflecting investor interest in technology and gold amid a market close to all-time highs [3][4]. - Investors are gravitating towards gold due to its recent price increase and technology stocks for growth opportunities [4]. Investment Strategies - Crossmark Investments has launched two ETFs focused on large-cap growth and large-cap value, which are attracting new investments, suggesting a shift from traditional SMAs and mutual funds to ETFs [5][6]. - The Crossmark Large Growth ETF (CLCG) targets growth stocks with reasonable valuations and high returns on equity, appealing to investors seeking growth and momentum [7][8]. - The Crossmark Large Value ETF (CLCV) focuses on value stocks, particularly in the financial sector, which are perceived as undervalued relative to the market [10][11]. Portfolio Management - A balanced investment approach is recommended, with investors encouraged to consider both growth and value ETFs to mitigate risks associated with being overly concentrated in growth stocks [12][13]. - The value ETF is seen as a complementary investment to the growth ETF, with some investors allocating equal amounts to both to achieve a balanced portfolio [12][13].

Core Insights - The article emphasizes the importance of value investing and highlights the Zacks Rank system as a tool for identifying winning stocks based on earnings estimates and revisions [1][2]. Company Analysis - Nexxen International Ltd. Sponsored ADR (NEXN) is identified as a stock to watch, currently holding a Zacks Rank of 2 (Buy) and an A for Value [3]. - NEXN has a P/E ratio of 8.59, which is lower than the industry average P/E of 9.71. Over the past year, NEXN's Forward P/E has fluctuated between 7.45 and 13.44, with a median of 10.09 [3]. - The company has a P/CF ratio of 5.45, significantly lower than the industry's average P/CF of 10.30. NEXN's P/CF has ranged from 5.15 to 18.41 over the past 52 weeks, with a median of 7.30 [4]. - The metrics suggest that NEXN is likely undervalued, supported by a strong earnings outlook, making it an attractive value stock [5].

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value ...